Next Gen Biotech

Knilonat 150mg capsule is an antineoplastic drug with an active ingredient called Nilotinib. It belongs to the medication class known as tyrosine kinase inhibitors. This medicine is used to treat a type of leukemia called  Philadelphia chromosome-positive chronic myeloid leukemia (Ph-positive CML), a blood cancer with abnormal production of WBC. In adult and pediatric patients, it is used in a patient who is newly diagnosed with Chronic Myeloid Leukemia (CML) and those facing side effects from previous treatment. Additionally, it is also used in patients with no longer respond to the previous treatment including Imatinib. 

Do not take this medicine if you are allergic to Nilotinib or the other ingredients of this medicine. Notify your doctor if you have or had a history of heart conditions (heart attack, abnormal electric signal), chest pain, brain stroke, or claudication ( condition of blood flow in the leg). Inform your doctor if you have liver or pancreas disorder, or suffering from a lack of potassium or magnesium. You need to tell your doctor about all the medications especially if you take medicine to lower your blood cholesterol. Tell your doctor about your underlying condition especially inform about if you have or ever had a hepatitis B infection; this medicine can activate HPV again which can be fatal in some cases. Avoid consuming grapefruit or grapefruit juice. Inform your doctor if you are intolerant to some sugar, as this medicine contains lactose. 

During the treatment, your doctor may conduct a regular blood test to monitor the liver and pancreas function, and the number of blood cells (WBC, RBC, platelets). Also to monitor the heart condition (prolongation of the QT interval), electrolytes in the body, and the level of sugar and fats to check how Knilonat 150mg capsule is tolerated. Inform your doctor if you are pregnant or planning to get pregnant or breastfeeding. Use effective birth control during the treatment with this medicine.

Nilosure 200mg capsule is an antineoplastic drug with an active ingredient called Nilotinib. It belongs to the medication class known as tyrosine kinase inhibitors. This medicine is used to treat a type of leukemia called  Philadelphia chromosome-positive chronic myeloid leukemia (Ph-positive CML), a blood cancer with abnormal production of WBC. In adult and pediatric patients, it is used in a patient who is newly diagnosed with Chronic Myeloid Leukemia (CML) and those facing side effects from previous treatment. Additionally, it is also used in patients with no longer respond to the previous treatment including Imatinib. 

Do not take this medicine if you are allergic to Nilotinib or the other ingredients of this medicine. Notify your doctor if you have or had a history of heart conditions (heart attack, abnormal electric signal), chest pain, brain stroke, or claudication ( condition of blood flow in the leg). Inform your doctor if you have liver or pancreas disorder, or suffering from a lack of potassium or magnesium. You need to tell your doctor about all the medications especially if you take medicine to lower your blood cholesterol. Tell your doctor about your underlying condition especially inform about if you have or ever had a hepatitis B infection; this medicine can activate HPV again which can be fatal in some cases. Avoid consuming grapefruit or grapefruit juice. Inform your doctor if you are intolerant to some sugar, as this medicine contains lactose. 

During the treatment, your doctor may conduct a regular blood test to monitor the liver and pancreas function, and the number of blood cells (WBC, RBC, platelets). Also to monitor the heart condition (prolongation of the QT interval), electrolytes in the body, and the level of sugar and fats to check how Nilosure 200mg is tolerated. Inform your doctor if you are pregnant or planning to get pregnant or breastfeeding. Use effective birth control during the treatment with this medicine.

Ninlib 150mg capsule is an antineoplastic drug with an active ingredient called Nilotinib. It belongs to the medication class known as tyrosine kinase inhibitors. This medicine is used to treat a type of leukemia called  Philadelphia chromosome-positive chronic myeloid leukemia (Ph-positive CML), a blood cancer with abnormal production of WBC. In adult and pediatric patients, it is used in a patient who is newly diagnosed with Chronic Myeloid Leukemia (CML) and those facing side effects from previous treatment. Additionally, it is also used in patients with no longer respond to the previous treatment including Imatinib.  

Do not take this medicine if you are allergic to Nilotinib or the other ingredients of this medicine. Notify your doctor if you have or had a history of heart conditions (heart attack, abnormal electric signal), chest pain, brain stroke, or claudication ( condition of blood flow in the leg). Inform your doctor if you have liver or pancreas disorder, or suffering from a lack of potassium or magnesium. You need to tell your doctor about all the medications especially if you take medicine to lower your blood cholesterol. Tell your doctor about your underlying condition especially inform about if you have or ever had a hepatitis B infection; this medicine can activate HPV again which can be fatal in some cases. Avoid consuming grapefruit or grapefruit juice. Inform your doctor if you are intolerant to some sugar, as this medicine contains lactose.  

During the treatment, your doctor may conduct a regular blood test to monitor the liver and pancreas function, and the number of blood cells (WBC, RBC, platelets). Also to monitor the heart condition (prolongation of the QT interval), electrolytes in the body, and the level of sugar and fats to check how Ninlib 150mg is tolerated. Inform your doctor if you are pregnant or planning to get pregnant or breastfeeding. Use effective birth control during the treatment with this medicine.

Ninlib 200mg capsule is an antineoplastic drug with an active ingredient called Nilotinib. It belongs to the medication class known as tyrosine kinase inhibitors. This medicine is used to treat a type of leukemia called  Philadelphia chromosome-positive chronic myeloid leukemia (Ph-positive CML), a blood cancer with abnormal production of WBC. In adult and pediatric patients, it is used in a patient who is newly diagnosed with Chronic Myeloid Leukemia (CML) and those facing side effects from previous treatment. Additionally, it is also used in patients with no longer respond to the previous treatment including Imatinib.  

Do not take this medicine if you are allergic to Nilotinib or the other ingredients of this medicine. Notify your doctor if you have or had a history of heart conditions (heart attack, abnormal electric signal), chest pain, brain stroke, or claudication ( condition of blood flow in the leg). Inform your doctor if you have liver or pancreas disorder, or suffering from a lack of potassium or magnesium. You need to tell your doctor about all the medications especially if you take medicine to lower your blood cholesterol. Tell your doctor about your underlying condition especially inform about if you have or ever had a hepatitis B infection; this medicine can activate HPV again which can be fatal in some cases. Avoid consuming grapefruit or grapefruit juice. Inform your doctor if you are intolerant to some sugar, as Ninlib 200mg contains lactose.  

During the treatment, your doctor may conduct a regular blood test to monitor the liver and pancreas function, and the number of blood cells (WBC, RBC, platelets). Also to monitor the heart condition (prolongation of the QT interval), electrolytes in the body, and the level of sugar and fats to check how Ninlib 200mg is tolerated. Inform your doctor if you are pregnant or planning to get pregnant or breastfeeding. Use effective birth control during the treatment with this medicine.

Knilonat 200mg capsule is an antineoplastic drug with an active ingredient called Nilotinib. It belongs to the medication class known as tyrosine kinase inhibitors. This medicine is used to treat a type of leukemia called  Philadelphia chromosome-positive chronic myeloid leukemia (Ph-positive CML), a blood cancer with abnormal production of WBC. In adult and pediatric patients, it is used in a patient who is newly diagnosed with Chronic Myeloid Leukemia (CML) and those facing side effects from previous treatment. Additionally, it is also used in patients with no longer respond to the previous treatment including Imatinib. 

Do not take this medicine if you are allergic to Nilotinib or the other ingredients of this medicine. Notify your doctor if you have or had a history of heart conditions (heart attack, abnormal electric signal), chest pain, brain stroke, or claudication ( condition of blood flow in the leg). Inform your doctor if you have liver or pancreas disorder, or suffering from a lack of potassium or magnesium. You need to tell your doctor about all the medications especially if you take medicine to lower your blood cholesterol. Tell your doctor about your underlying condition, especially if you have or ever had a hepatitis B infection; this medicine can activate HPV again which can be fatal in some cases. Avoid consuming grapefruit or grapefruit juice. Inform your doctor if you are intolerant to some sugar, as this medicine contains lactose. 

During the treatment, your doctor may conduct a regular blood test to monitor the liver and pancreas function, and the number of blood cells (WBC, RBC, platelets). Also to monitor the heart condition (prolongation of the QT interval), electrolytes in the body, and the level of sugar and fats to check how Knilonat 200mg capsule is tolerated. Inform your doctor if you are pregnant or planning to get pregnant or breastfeeding. Use effective birth control during the treatment with this medicine.